现代小细胞肺癌脑转移放疗的国家趋势
该回顾性研究利用2010至2021年美国国家癌症数据库,分析24,858例接受脑部放疗的小细胞肺癌脑转移成人患者。随 time 推移,海马保护全脑放疗和立体定向放射外科的使用显著增加;这两种技术与全脑放疗相比中位生存期更长(分别为10.6和10.1个月 vs 7.3个月)。作者指出选择偏倚和回顾性设计限制确定性结论。
要点
- 2010至2021年间,海马保护全脑放疗和立体定向放射外科的使用显著增加。
- 立体定向放射外科和海马保护全脑放疗的中位生存期分别为10.6和10.1个月,全脑放疗为7.3个月。
- 高龄、颅外疾病和较高合并症评分与较差生存相关;化疗、免疫治疗和较高社会经济地位与改善结局相关。
核心结论
- 2010至2021年间,治疗小细胞肺癌脑转移的先进技术使用增加,这些技术与改善的生存结局相关,但选择偏倚和研究的回顾性性质限制确定性结论。
研究设计与样本
- 回顾性研究,使用2010至2021年美国国家癌症数据库,纳入接受脑部原发放疗的小细胞肺癌脑转移成人患者24,858例,中位年龄65岁,分为全脑放疗、海马保护全脑放疗和立体定向放射外科3组,进行逻辑回归、Kaplan-Meier生存分析和Cox回归。
主要发现
- 随时间推移,先进放疗技术(海马保护全脑放疗和立体定向放射外科)的使用显著增加。
- 立体定向放射外科和海马保护全脑放疗的中位生存期分别为10.6和10.1个月,全脑放疗为7.3个月。
- 高龄、颅外疾病和较高合并症评分与较差生存相关,而化疗、免疫治疗和较高社会经济地位与改善结局相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 选择偏倚和研究的回顾性性质限制确定性结论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Small cell lung cancer (SCLC) is a highly aggressive form of lung cancer that often leads to brain metastases. Traditional treatment has largely relied on whole brain radiation therapy (WBRT). However, concerns about neurocognitive side effects have led to the adoption of advanced techniques such as hippocampal avoidance WBRT (HA-WBRT) and stereotactic radiosurgery (SRS). METHODS AND MATERIALS: This retrospective study used data from the National Cancer Database spanning from 2010 to 2021. The study included adult patients diagnosed with brain metastases from SCLC who received primary radiation therapy directed at the brain. Patients were categorized into 3 treatment groups: WBRT, HA-WBRT, and SRS. Statistical analyses, including logistic regression, Kaplan-Meier survival analysis, and Cox regression, were performed to identify predictors of treatment type and survival outcomes. RESULTS: The study analyzed 24,858 patients with a median age of 65 years. Over time, there was a significant increase in the use of advanced radiation techniques (HA-WBRT and SRS). SRS and HA-WBRT were associated with longer median survival (10.6 and 10.1 months, respectively) than WBRT (7.3 months). Factors such as advanced age, extracranial disease, and higher comorbidity scores were linked to poorer survival, whereas the use of chemotherapy, immunotherapy, and higher socioeconomic status were associated with improved outcomes. CONCLUSIONS: From 2010 to 2021, there has been an increase in the use of more advanced techniques to treat brain metastasis from SCLC. These advanced techniques were associated with improved survival outcomes, although selection bias and the retrospective nature of the study limit definitive conclusions.
引用
- Desai J, Rajkumar S, Shepard MJ, et al. National Trends in Radiation Treatment for Small Cell Lung Cancer Brain Metastases in the Modern Era. Adv Radiat Oncol. 2025. PMID: 40041762. doi:10.1016/j.adro.2025.101720
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。